1. GPCR Adaptation and Regulation of Ion Channels

The plasma membrane of eukaryotic cells contains GPCRs (G-protein-coupled receptors) that translate extracellular chemical cues into intracellular responses. While GPCRs typically signal through downstream enzymatic second-messenger cascades, they can also directly regulate ion channel conductance or undergo complex adaptation protocols that control signal duration and sensitivity.

1.1 Direct Gating of Ion Channels by Heterotrimeric G-Proteins

G-proteins do not act exclusively by regulating enzymes that alter second-messenger concentration. In many physiologically critical pathways, activated G-protein subunits bind directly to ion channels in the plasma membrane, modifying ionic permeability, electrical excitability, and membrane potential. A classic example is the regulation of cardiac pacemaking by acetylcholine (ACh) released from the vagus nerve.

1. ACh binding: acetylcholine released into the synaptic cleft binds muscarinic acetylcholine receptors (mAChRs) — specifically the M₂ subtype — on pacemaker cells of the sinoatrial (SA) node and cardiac muscle.
2. G-protein activation: the M₂ receptor is coupled to the inhibitory heterotrimeric G-protein G_i. ACh binding drives a conformational change that promotes GDP–GTP exchange on the α_i subunit.
3. Subunit dissociation: GTP binding causes the G_i heterotrimer to dissociate into an active G_iα–GTP monomer and a free, highly active G_βγ complex.
4. Direct channel gating: G_iα–GTP inhibits adenylyl cyclase intracellularly, lowering cAMP and PKA activity and reducing opening of L-type calcium channels and HCN "funny" channels. Simultaneously, free G_βγ diffuses in the membrane and binds directly to the cytosolic domains of GIRK (K_ACh) channels.
5. Hyperpolarisation: direct G_βγ binding opens GIRK channels, allowing rapid K⁺ efflux down its gradient. This hyperpolarises the membrane, moving it closer to E_K (≈ −90 mV) and making threshold harder to reach.
6. Physiological outcome: this dual mechanism reduces both the rate of pacemaking (negative chronotropy) and the strength of contraction (negative inotropy).

1.2 Indirect Channel Regulation via Second Messengers

Other G-proteins regulate ion channels less directly — either by stimulating channel phosphorylation (via PKA, PKC, or CaM-kinase) or by altering the production or destruction of cyclic nucleotides (cAMP or cGMP) that directly activate or inactivate cyclic nucleotide-gated ion channels.

2. GPCR Adaptation: Desensitisation, Internalisation, and Down-Regulation

Target cells can adjust their sensitivity to extracellular signals. Under prolonged or repeated ligand exposure, receptor responsiveness decreases progressively. This reversible adaptation (desensitisation) prevents overstimulation and maintains homeostasis. For GPCRs it is governed by a coordinated, multi-stage pathway involving receptor phosphorylation, steric uncoupling, endocytosis, and lysosomal degradation.

2.1 Receptor Desensitisation (Seconds to Minutes)

1. GRK-mediated phosphorylation: a GPCR that remains ligand-bound for a prolonged period becomes a substrate for GPCR kinases (GRKs), which phosphorylate multiple serine/threonine residues on the cytosolic C-terminal tail and third intracellular loop of the active receptor.
2. Arrestin recruitment: phosphorylation of these residues creates a high-affinity docking site for the cytosolic regulatory protein arrestin.
3. Steric uncoupling: arrestin binding sterically blocks the cytosolic face of the receptor, physically preventing G-protein association and terminating downstream signalling even while ligand remains bound.
4. Heterologous desensitisation: alongside GRKs (which act only on the active receptor — homologous desensitisation), second-messenger kinases PKA and PKC can phosphorylate both active and inactive GPCRs, letting one strongly stimulated pathway desensitise unrelated receptors too.
5. Intracellular G-protein inactivation: RGS proteins (Regulators of G-protein Signaling) act as GTPase-activating proteins for Gα subunits, sharply accelerating GTP hydrolysis and returning the G-protein to its inactive heterotrimeric state.

2.2 Receptor Internalisation (Minutes)

1. Endocytic machinery: arrestin acts as an adapter, interacting directly with clathrin and the adaptor complex AP2, recruiting the GPCR into invaginating clathrin-coated pits.
2. Vesicle budding: the GTPase dynamin drives vesicle constriction and scission from the plasma membrane, releasing the GPCR inside a clathrin-coated vesicle.
3. Receptor sequestration: the vesicle uncoats and fuses with early endosomes, where the acidic environment causes ligand dissociation. If endosomal phosphatases dephosphorylate the receptor, arrestin detaches and the cleared receptor is recycled back to the plasma membrane, restoring sensitivity.

2.3 Receptor Down-Regulation (Hours)

3. The Nitric Oxide (NO) Paracrine Signalling Pathway

Nitric oxide (NO) is a short-lived, gaseous paracrine signal that regulates local physiological processes, most notably the relaxation of vascular smooth muscle. Being small and hydrophobic, NO bypasses traditional membrane-bound receptors and diffuses directly across lipid bilayers to act on cytosolic target proteins.

3.1 Enzymatic Synthesis of Nitric Oxide

NO is synthesised intracellularly from L-arginine by nitric oxide synthase (NOS):

3.2 The Endothelial–Smooth Muscle Vasodilation Cascade

Vasodilation is a coordinated intercellular cascade between endothelial cells lining the vessel lumen and the surrounding smooth muscle cells.

1. Endothelial stimulation: acetylcholine, released by autonomic nerves or generated by vascular shear stress, binds M₃ muscarinic receptors on endothelial cells.
2. IP₃–calcium pathway: M₃ activation stimulates phospholipase C via G_q, cleaving PI(4,5)P₂ into DAG and IP₃. IP₃ binds ligand-gated receptors on the ER membrane, triggering rapid cytosolic Ca²⁺ release.
3. NOS activation: elevated Ca²⁺ binds calmodulin; the Ca²⁺–calmodulin complex binds and activates eNOS.
4. NO diffusion: active eNOS converts L-arginine into NO and L-citrulline. Being a gas, NO diffuses freely and rapidly out of the endothelial cell and across the membrane of adjacent smooth muscle cells.
5. sGC activation: inside the smooth muscle cell, NO binds with very high affinity to the heme iron of soluble guanylyl cyclase, its cytosolic receptor.
6. cGMP production: NO binding drives a conformational change that increases sGC activity, converting cytosolic GTP into cGMP.
7. PKG activation and relaxation: cGMP activates Protein Kinase G, which phosphorylates several targets to lower cytosolic calcium and contractile sensitivity — inhibiting L-type Ca²⁺ channels, activating SERCA/phospholamban to re-uptake Ca²⁺, opening Ca²⁺-activated K⁺ channels, and activating myosin light-chain phosphatase, which directly relaxes the muscle.

3.3 Termination of the Signal: NO Half-Life and PDE-5

NO acts only locally because its extracellular half-life is only about 5–10 seconds before it reacts with O₂ and H₂O to form inactive nitrates and nitrites. The intracellular cGMP signal is separately terminated by phosphodiesterases — predominantly PDE-5 — which hydrolyse cGMP to inactive 5′-GMP.

4. Enzyme-Linked Cell-Surface Receptors

Enzyme-linked receptors are the second major class of eukaryotic cell-surface receptors. Like GPCRs, they are transmembrane proteins with their ligand-binding domain on the extracellular face of the plasma membrane. Instead of coupling to a separate heterotrimeric G-protein, however, their cytosolic domains either possess intrinsic enzymatic activity themselves or associate directly with an independent cytosolic enzyme.

5. Receptor Tyrosine Kinases (RTKs) and Autophosphorylation

RTKs are the most numerous and best-characterised class of enzyme-linked receptors. They mediate the actions of a diverse array of extracellular growth factors and hormones, including insulin, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and colony stimulating factor-1 (CSF-1).

5.1 Structural Topology

An RTK monomer typically consists of three domains:

1. Extracellular ligand-binding domain: highly glycosylated, containing structural motifs such as immunoglobulin-like domains, fibronectin-type-III-like domains, or cysteine-rich domains.
2. Transmembrane α-helix: a single, hydrophobic segment spanning the plasma membrane.
3. Cytosolic domain: contains a conserved kinase catalytic pocket alongside regulatory regions rich in tyrosine residues.

5.2 Dimerization and Trans-Autophosphorylation

In the absence of extracellular ligand, most RTKs exist in the plasma membrane as inactive, monomeric proteins. Ligand binding drives a precise structural sequence that switches the receptor on.

1. Ligand binding: an extracellular ligand — often a dimer itself, such as PDGF, or one that induces a conformational change favouring dimerization, such as EGF — brings two monomeric RTK polypeptides into close spatial proximity, forming a stable homodimer or heterodimer.
2. Trans-autophosphorylation: dimerization positions the two cytosolic kinase domains adjacent to one another. The kinase domain of one monomer phosphorylates specific tyrosine residues in the catalytic loop and regulatory tail of the opposite monomer, and vice versa.
3. Kinase activation: phosphorylation of tyrosines within the active-site activation loop (e.g. Tyr-1158, 1162, and 1163 in the insulin receptor) induces a conformational shift that opens the catalytic pocket, increasing kinase activity toward downstream substrates.
4. Docking site creation: phosphorylation of tyrosines outside the catalytic domain, in the juxtamembrane or C-terminal regions, generates highly specific phosphotyrosine docking sites on the cytosolic face of the receptor.

5.3 Intracellular Docking Domains: SH2 and PTB

The newly formed phosphotyrosines on the active RTK function as high-affinity binding sites for intracellular signalling proteins carrying one of two conserved recognition domains.

6. The Ras-MAP Kinase Pathway

The Ras-MAP kinase pathway is one of the primary signalling routes activated by RTKs to regulate gene expression, cell proliferation, differentiation, and survival. It links activation of a membrane-bound monomeric GTPase to a sequential cytosolic serine/threonine phosphorylation cascade.

6.1 Ras: The Monomeric GTPase Switch

Ras is a monomeric, lipid-linked GTPase of ≈21 kDa, covalently anchored to the cytosolic leaflet of the plasma membrane via a C-terminal prenyl or palmitoyl group. Like all monomeric GTPases, it acts as a binary molecular switch — inactive when GDP-bound, active when GTP-bound. Cyclic interconversion between these states is tightly regulated by two classes of accessory proteins.

6.2 The Grb2–Sos Adaptor Complex

The structural bridge connecting an activated RTK to the Ras switch is built from two cytosolic helper proteins with no intrinsic enzymatic activity of their own: Grb2 (one central SH2 domain flanked by two SH3 domains) and Sos, a Ras-specific GEF whose proline-rich motifs bind constitutively to Grb2's SH3 domains.

1. Docking: upon RTK autophosphorylation, the SH2 domain of the cytosolic Grb2–Sos complex binds directly to a specific phosphotyrosine on the receptor's cytosolic tail.
2. Relocation: this docking event physically moves Sos from the bulk cytosol to the cytosolic face of the plasma membrane, placing it next to its membrane-anchored substrate, Ras.
3. Nucleotide exchange: Sos engages Ras-GDP, displacing bound GDP and allowing GTP to bind, converting Ras into its active Ras-GTP state.

6.3 The MAP Kinase Phosphorylation Cascade

Active Ras-GTP initiates a downstream three-tier kinase module — the mitogen-activated protein (MAP) kinase cascade.

1. Raf (MAPKKK): Ras-GTP recruits cytosolic Raf-1 to the membrane; this recruitment triggers a conformational change and phosphorylation event that fully activates Raf. Hydrolysis of Ras-GTP subsequently releases active Raf back into the cytosol.
2. MEK (MAPKK): active Raf phosphorylates MEK on two conserved regulatory serines. MEK is a unique dual-specificity kinase, able to phosphorylate both tyrosine and serine/threonine residues on its substrate.
3. ERK (MAPK): active MEK phosphorylates ERK on both a tyrosine and a threonine within its activation loop — this dual phosphorylation is strictly required for ERK activation.
4. Downstream targets: ERK phosphorylates cytoskeletal elements and cytosolic kinases in the cytoplasm, and also dimerises and translocates into the nucleus, where it activates transcription factors (e.g. Elk-1, Ets-1, c-Myc) that drive immediate-early genes (c-fos, c-jun, c-myc) critical for G1-to-S cell-cycle progression.

7. The PI3K–Akt (PKB) and mTOR Signalling Network

The PI3K/Akt pathway is the primary intracellular signalling route mediating cell survival, growth, metabolism, and protein translation in response to insulin and extracellular growth factors.

7.1 Phosphorylation of the Inositol Ring

Upon RTK activation, the cytosolic lipid kinase PI3K — via an SH2 domain that binds autophosphorylated receptor tyrosines (or adaptors such as IRS) — is recruited to the membrane. Once active and membrane-localised, PI3K phosphorylates the 3-position hydroxyl of the inositol ring of membrane phosphoinositides, converting PI(4,5)P₂ into the lipid second messenger PI(3,4,5)P₃ (PIP3).

7.2 The PH Domain and Recruitment of Akt and PDK1

Unlike soluble second messengers such as IP₃, PIP3 remains anchored in the cytosolic leaflet of the membrane, acting as a docking platform for proteins bearing a PH (Pleckstrin Homology) domain. Akt binds PIP3 directly, exposing its activation loop; PDK1, also PH-domain-containing, is recruited alongside it.

7.3 Multi-Site Phosphorylation and Activation of Akt

1. Activation loop phosphorylation: PDK1 phosphorylates Akt at Thr-308 within its activation loop, structurally opening the catalytic cleft.
2. Hydrophobic motif phosphorylation: mTORC2 phosphorylates Akt at Ser-473 in its C-terminal hydrophobic motif, stabilising the active conformation.

8. Insulin Receptor Signalling and Metabolic Homeostasis

The Insulin Receptor (INS-R) is a unique member of the RTK family. Unlike most RTKs, which exist as monomers until ligand binding, the insulin receptor is a pre-formed α₂β₂ heterotetramer held together by covalent disulfide bonds.

8.1 Signal Propagation through IRS Adapters

1. Insulin binding: insulin binds the extracellular α-subunits, triggering a structural realignment that activates the tyrosine kinase domains of the transmembrane β-subunits.
2. Autophosphorylation: the β-subunits undergo trans-autophosphorylation on several key tyrosine residues.
3. IRS recruitment: instead of binding SH2 proteins directly, the phosphorylated receptor recruits large cytosolic docking proteins — IRS-1/2 and Shc — via their PTB domains, which are then themselves phosphorylated on multiple tyrosines, creating an amplified docking platform.
4. Pathway split: phosphorylated IRS recruits PI3K to drive the metabolic PIP3–Akt cascade, while phosphorylated IRS/Shc recruits Grb2–Sos to initiate the mitogenic Ras–MAP kinase pathway.

8.2 Downstream Metabolic Regulators

1. Glycogen synthesis activation: Akt phosphorylates and inactivates GSK3 (Glycogen Synthase Kinase 3). Active, unphosphorylated GSK3 normally inhibits glycogen synthase; once GSK3 is inactivated, glycogen synthase stays active, accelerating glycogen synthesis from glucose.
2. GLUT4 vesicle translocation: in skeletal muscle and adipose tissue, GLUT4 is normally sequestered in intracellular storage vesicles. Active Akt phosphorylates Rab-GAPs (AS160), allowing active Rab GTPases to drive trafficking, docking, and fusion of GLUT4 vesicles with the plasma membrane, rapidly increasing glucose uptake.
3. Lipid and protein synthesis: Akt stimulates mTORC1 (promoting translation and protein synthesis) and activates lipogenic transcription factors such as SREBP-1c to promote fatty acid synthesis.

9. The mTORC1 and mTORC2 Complexes and Cell Growth

The protein kinase mTOR (mammalian Target of Rapamycin) is an atypical, large (≈290 kDa) serine/threonine kinase of the PI3K-related kinase (PIKK) family. It is the master sensor integrating nutrient levels, energy status (ATP/AMP ratio), and growth factor signals to regulate cell growth and division, and functions in two biochemically distinct multiprotein complexes.

9.1 The Tsc1/Tsc2–Rheb GTPase Switch

The primary route linking growth-factor-activated Akt to mTORC1 activation runs through Rheb (Ras homolog enriched in brain), a small monomeric GTPase.

1. Rheb inactivation by Tsc2: the Tsc1(hamartin)/Tsc2(tuberin) GAP complex stimulates Rheb's intrinsic GTPase activity, converting Rheb-GTP to inactive Rheb-GDP and keeping mTORC1 off.
2. Akt-mediated phosphorylation: in the presence of growth factors, active Akt phosphorylates Tsc2 at multiple conserved residues.
3. Inhibition of Rheb GAP: this phosphorylation inactivates the Tsc1/Tsc2 complex, causing it to dissociate from Rheb.
4. mTORC1 activation: uninhibited Rheb exchanges GDP for GTP; Rheb-GTP binds mTORC1 directly, activating its kinase domain and driving cell growth and protein translation.

10. Tyrosine Kinase–Associated Receptors and the JAK-STAT Pathway

Many receptors mediating the effects of cytokines (interleukins, interferons) and polypeptide hormones (growth hormone, prolactin, erythropoietin) lack intrinsic enzymatic activity. Instead they operate as Tyrosine Kinase–Associated Receptors that stably recruit and activate cytosolic tyrosine kinases upon ligand binding, transducing signals to the nucleus via the direct, rapid JAK-STAT pathway.

10.1 The JAK and STAT Families

The associated cytosolic tyrosine kinases are called Janus Kinases (JAKs) — named for their two adjacent kinase-like domains, one catalytic and one regulatory. The four mammalian members are JAK1, JAK2, JAK3, and Tyk2. Their downstream effectors, STATs (Signal Transducers and Activators of Transcription), are latent cytosolic transcription factors carrying a conserved SH2 domain, a central DNA-binding domain, and a critical C-terminal regulatory tyrosine.

10.2 Step-by-Step Transduction Mechanism

1. Dimerization: ligand binding induces receptor dimerization (or oligomerisation), or reorients a pre-formed dimer.
2. JAK cross-phosphorylation: dimerization brings the stably associated cytosolic JAKs into proximity, allowing them to cross-phosphorylate and activate one another on conserved tyrosines.
3. Receptor phosphorylation: active JAKs phosphorylate specific tyrosines on the cytosolic domains of the cytokine receptor.
4. STAT recruitment: the phosphorylated receptor tyrosines act as docking sites for the SH2 domains of cytosolic STAT monomers.
5. STAT phosphorylation: once docked, the C-terminal tyrosine of the STAT monomer is phosphorylated by the active JAK.
6. Dimerization and translocation: phosphorylated STATs dissociate from the receptor and dimerise with one another via reciprocal SH2–phosphotyrosine interactions.
7. Nuclear transcription: the STAT dimer exposes a nuclear localisation signal and translocates through the nuclear pore complex, binding promoter response elements (e.g. ISRE) to activate target-gene transcription.

11. Receptor Serine/Threonine Kinases and the Smad Pathway

The Transforming Growth Factor-β (TGF-β) superfamily — TGF-βs, activins, and bone morphogenetic proteins (BMPs) — signals through single-pass transmembrane receptors bearing intrinsic cytosolic serine/threonine kinase domains.

11.1 Type I and Type II Receptor Stoichiometry

The active receptor complex is a heterotetrameric assembly of two homodimeric pairs. Type II receptors are stably active Ser/Thr kinases that constitutively autophosphorylate even without ligand. Type I receptors are Ser/Thr kinases whose activity is blocked by an auto-inhibitory N-terminal GS (glycine-serine-rich) domain until released by Type II.

11.2 The Phosphorylation Relay of Smads

1. Ligand binding and heterotetramerisation: dimeric TGF-β binds the Type II homodimer, which recruits the Type I homodimer to form a stable heterotetramer.
2. Type I activation: the adjacent active Type II receptor phosphorylates serine/threonine residues in the GS domain of Type I, releasing auto-inhibition and activating its kinase.
3. R-Smad recruitment and phosphorylation: active Type I receptor recruits and phosphorylates R-Smads at a conserved C-terminal SSXS motif — Smad2/3 for TGF-β/activin signalling, Smad1/5/8 for BMP signalling.
4. Co-Smad complex assembly: phosphorylated R-Smad undergoes a conformational change exposing its interaction surface, forming a complex with the common partner Smad4 (co-Smad), shared by all TGF-β superfamily pathways.
5. Nuclear translocation: the R-Smad/co-Smad complex enters the nucleus and, with other co-activators or co-repressors, binds Smad-Binding Elements (SBE) on DNA to regulate target-gene transcription.

12. Classification of Protein Kinases and Phosphatases

Protein phosphorylation is the most common regulatory post-translational modification in cell signalling. The balance of signalling states is governed by the opposing actions of protein kinases, which transfer a phosphate group from ATP to specific amino acid side chains, and protein phosphatases, which hydrolytically remove it.

12.1 Chemical Classification of Protein Kinases

12.2 Biochemical Classification of Protein Phosphatases

13. Bacterial Chemotaxis and Two-Component Signalling Systems

Bacterial cells possess sophisticated sensory transduction networks to navigate their chemical environment. The most thoroughly characterised pathway is chemotaxis in Escherichia coli, which relies on a specialised two-component signalling system to regulate flagellar motor rotation.

13.1 The Physical Mechanics of Bacterial Motility

E. coli swim by rotating rigid, helical flagella driven by a basal rotary motor powered by proton motive force (via MotA/MotB stator channels). The direction of rotation dictates behaviour: counter-clockwise (CCW) rotation bundles the flagella behind the cell for a smooth, straight run; clockwise (CW) rotation flies the bundle apart, causing a random reorientation, or tumble.

13.2 The Transduction Pathway

1. Receptor complex: MCPs (Methyl-Accepting Chemotaxis Proteins) are coupled on their cytosolic face to the adaptor CheW and the sensor histidine kinase CheA.
2. Repellent-stimulated autophosphorylation: binding of a repellent (or loss of an attractant) stabilises the MCP's active state, stimulating CheA to autophosphorylate a conserved histidine using ATP.
3. Phosphate transfer: active CheA–phosphate rapidly transfers its phosphate to a conserved aspartate (Asp-57) on the response regulator CheY, generating CheY–P.
4. Motor binding: CheY–P diffuses through the cytosol and binds the switch protein FliG on the flagellar motor, shifting rotation from default CCW to CW and initiating a tumble.
5. Signal termination: the phosphatase CheZ binds CheY–P and accelerates its dephosphorylation, restoring CCW rotation (runs) so the cell can keep sampling its environment.

13.3 Receptor Adaptation: The CheR/CheB Methylation Circuit

To detect gradients spanning several orders of magnitude, MCP sensitivity is tuned by reversible covalent methylation. The constitutive methyltransferase CheR continuously adds methyl groups from SAM to glutamate residues on the MCP — high methylation desensitises the receptor and promotes tumbles. Active CheB–P removes those methyl groups, resensitising the receptor and promoting runs.

14. Bacterial Quorum Sensing

Quorum sensing is a density-dependent bacterial communication phenomenon that coordinates gene expression across a population in response to local cell density, regulating group behaviours such as bioluminescence, biofilm formation, virulence, competence, and sporulation.

14.1 Gram-Negative Quorum Sensing: The LuxI/LuxR System

First discovered in the marine symbiont Vibrio fischeri, this system uses small, membrane-permeable lipid autoinducers called N-acyl-homoserine lactones (AHLs).

1. Synthesis: the enzyme LuxI continuously synthesises AHL at a low basal rate; AHL diffuses freely out of the cell.
2. Accumulation: at low population density AHL is rapidly diluted away, but as density rises (e.g. within the bobtail squid's light organ) AHL accumulates both extra- and intracellularly.
3. Activation: once a threshold concentration is reached, internal AHL binds directly to the cytosolic transcription factor LuxR.
4. Gene expression: AHL binding stabilises LuxR, letting it dimerise and bind the lux box promoter, activating the luxICDABEG operon — encoding both LuxI (a positive-feedback loop) and the luciferase complex that produces blue-green bioluminescence.

14.2 Gram-Positive Quorum Sensing: Peptide-Mediated Pathways

Gram-positive bacteria use small, modified oligopeptide autoinducers. Because these peptides are charged and polar, they cannot diffuse passively across the membrane.

1. Export: peptides are actively exported via specialised ABC transporters.
2. Extracellular detection: the accumulating peptide autoinducer binds a membrane-bound sensor histidine kinase of a two-component system.
3. Signal relay: the sensor kinase autophosphorylates and transfers its phosphate to a cytosolic response regulator, which binds DNA to activate transcription of density-dependent virulence or competence genes.

15. Biophysics of Receptor–Ligand Interactions: Derivations and Scatchard Analysis

Understanding the physical chemistry of ligand binding is essential for quantifying receptor affinity, drug potency, and the stoichiometric properties of receptor complexes.

15.1 Thermodynamic Formulation of Binding

Consider a simple, reversible, non-covalent interaction between a receptor (R) and a ligand (L) at equilibrium:

At equilibrium, the rate of association equals the rate of dissociation, defining the equilibrium dissociation constant K_d:

K_d has units of molarity, and physically represents the free ligand concentration at which exactly half of the total receptor population is bound. A lower K_d means higher affinity.

15.2 Fractional Saturation and the Hill–Langmuir Equation

Fractional saturation (Y) is the ratio of bound to total receptor:

Solving the K_d expression for free receptor, [R] = K_d[RL]/[L], and substituting back into the saturation equation, the [RL] terms cancel to give the classical Hill–Langmuir equation for a single binding site:

15.3 The Linear Scatchard Transformation

Hyperbolic curves are hard to read precisely for affinity and receptor number, so the equation is transformed into a linear form. For a receptor with n equivalent, independent binding sites:

Multiplying out and rearranging in terms of Y/[L] gives the Scatchard equation — plotting bound/free (Y/[L]) against bound (Y) produces a straight line:

Slope = −1/K_d  ·  x-intercept = n (total binding sites)  ·  y-intercept = n/K_d

15.4 Non-Linear Scatchard Plots: Heterogeneity and Cooperativity

Many real Scatchard plots curve rather than forming a single straight line, for two distinct physical reasons.

16. Comprehensive Overview of Signalling Pathway Architectures

A side-by-side comparison of the structural features, kinetic profiles, and primary physiological functions of the receptor classes covered in this document.